IonQ (IONQ) 10-Q 16 Aug 21 2021 Q2 Quarterly report Financial data

Cover Page

Cover Page - shares	6 Months Ended
	Jun. 30, 2021	Aug. 16, 2021
Entity Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Jun. 30, 2021
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q2
Entity Registrant Name	dMY Technology Group, Inc. III
Entity Central Index Key	0001824920
Current Fiscal Year End Date	--12-31
Document Quarterly Report	true
Document Transition Report	false
Entity Incorporation, State or Country Code	DE
Entity File Number	001-39694
Entity Tax Identification Number	85-2992192
Entity Address, Address Line One	1180 North Town Center Drive
Entity Address, Address Line Two	Suite 100
Entity Address, City or Town	Las Vegas
Entity Address, State or Province	NV
Entity Address, Postal Zip Code	89144
City Area Code	702
Local Phone Number	781-4313
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Shell Company	true
Entity Ex Transition Period	false
Capital Units [Member]
Entity Information [Line Items]
Trading Symbol	DMYI.U
Title of 12(b) Security	Units, each consisting of one Class A common stock, $0.0001 par value, and one-fourth of one redeemable warrant
Security Exchange Name	NYSE
Common Class A [Member]
Entity Information [Line Items]
Trading Symbol	DMYI
Title of 12(b) Security	Class A common stock, par value $0.0001 per share
Security Exchange Name	NYSE
Entity Common Stock, Shares Outstanding		30,000,000
Warrant [Member]
Entity Information [Line Items]
Trading Symbol	DMYI WS
Title of 12(b) Security	Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share
Security Exchange Name	NYSE
Common Class B [Member]
Entity Information [Line Items]
Entity Common Stock, Shares Outstanding		7,500,000

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($)	Jun. 30, 2021	Dec. 31, 2020
Current assets:
Cash	$ 170	$ 1,569,739
Prepaid assets	711,544	770,285
Total current assets	711,714	2,340,024
Investments held in Trust Account	300,083,934	300,030,565
Total Assets	300,795,648	302,370,589
Current liabilities:
Accounts payable	313,509	850,442
Accrued expenses	3,550,285	512,509
Franchise tax payable	100,050	58,132
Due to related parties	156,366	31,366
Total current liabilities	4,120,210	1,452,449
Deferred underwriting commissions in connection with the initial public offering	10,500,000	10,500,000
Derivative warrant liabilities	40,600,000	34,885,000
Total liabilities	55,220,210	46,837,449
Commitments and Contingencies (Note 5)
Class A common stock, $0.0001 par value; 380,000,000 shares authorized; 24,057,543 and 25,053,313 shares subject to possible redemption at $10.00 per share as of June 30, 2021 and December 31, 2020, respectively	240,575,430	250,533,130
Stockholders' Equity:
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding	0	0
Additional paid-in capital	31,170,964	21,213,363
Accumulated deficit	(26,172,300)	(16,214,598)
Total stockholders' equity	5,000,008	5,000,010
Total Liabilities and Stockholders' Equity	300,795,648	302,370,589
Common Class A [Member]
Stockholders' Equity:
Common stock, value	594	495
Common Class B [Member]
Stockholders' Equity:
Common stock, value	$ 750	$ 750

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Jun. 30, 2021	Dec. 31, 2020
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	1,000,000	1,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common Class A [Member]
Temporary Equity, Par or Stated Value Per Share	$ 0.0001	$ 0.0001
Temporary Equity, Shares Authorized	380,000,000	380,000,000
Temporary Equity, Shares Outstanding	24,057,543	25,053,313
Temporary equity redemption price per share	$ 10	$ 10
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	380,000,000	380,000,000
Common stock, shares issued	5,942,457	4,946,687
Common stock, shares outstanding	5,942,457	4,946,687
Common Class B [Member]
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	20,000,000	20,000,000
Common stock, shares issued	7,500,000	7,500,000
Common stock, shares outstanding	7,500,000	7,500,000

Condensed Consolidated Statemen

Condensed Consolidated Statement Of Operations - USD ($)	3 Months Ended	6 Months Ended
	Jun. 30, 2021	Jun. 30, 2021
General and administrative expenses	$ 376,809	$ 4,194,577
Franchise tax expense	50,000	101,531
Loss from operations	(426,809)	(4,296,108)
Interest income earned in operating account	4	37
Gain on marketable securities (net), dividends and interest, held in Trust Account	6,545	53,369
Change in fair value of derivative warrant liabilities	(7,510,000)	(5,715,000)
Net loss	$ (7,930,260)	$ (9,957,702)
Class A Shares [Member]
Weighted average shares outstanding, basic and diluted	30,000,000	30,000,000
Basic and diluted net loss per share	$ 0	$ 0
Class B Shares [Member]
Net loss		$ (9,957,702)
Weighted average shares outstanding, basic and diluted	7,500,000	7,500,000
Basic and diluted net loss per share	$ (1.06)	$ (1.33)

Condensed Consolidated Statem_2

Condensed Consolidated Statement Of Changes In Stockholder's Equity - USD ($)	Total	Additional Paid-In Capital [Member]	Accumulated Deficit [Member]	Class A Shares [Member]Common Stock [Member]	Class B Shares [Member]	Class B Shares [Member]Common Stock [Member]
Balance at Dec. 31, 2020	$ 5,000,010	$ 21,213,363	$ (16,214,598)	$ 495		$ 750
Balance (in shares) at Dec. 31, 2020				4,946,687		7,500,000
Common stock subject to possible redemption	2,027,440	2,027,420		$ 20
Common stock subject to possible redemption (in shares)				202,744
Net loss	(2,027,442)		(2,027,442)		$ (7,930,260)
Balance at Mar. 31, 2021	5,000,008	23,240,783	(18,242,040)	$ 515		$ 750
Balance (in shares) at Mar. 31, 2021				5,149,431		7,500,000
Balance at Dec. 31, 2020	5,000,010	21,213,363	(16,214,598)	$ 495		$ 750
Balance (in shares) at Dec. 31, 2020				4,946,687		7,500,000
Net loss	(9,957,702)				$ (9,957,702)
Balance at Jun. 30, 2021	5,000,008	31,170,964	(26,172,300)	$ 594		$ 750
Balance (in shares) at Jun. 30, 2021				5,942,457		7,500,000
Balance at Mar. 31, 2021	5,000,008	23,240,783	(18,242,040)	$ 515		$ 750
Balance (in shares) at Mar. 31, 2021				5,149,431		7,500,000
Common stock subject to possible redemption (in shares)				793,026
Common stock subject to possible redemption	7,930,260	7,930,181		$ 79
Net loss	(7,930,260)		(7,930,260)
Balance at Jun. 30, 2021	$ 5,000,008	$ 31,170,964	$ (26,172,300)	$ 594		$ 750
Balance (in shares) at Jun. 30, 2021				5,942,457		7,500,000

Condensed Consolidated Statem_3

Condensed Consolidated Statement Of Cash Flows	6 Months Ended
	Jun. 30, 2021USD ($)
Cash Flows from Operating Activities:
Net loss	$ (9,957,702)
Adjustments to reconcile net loss to net cash used in operating activities:
Change in fair value of derivative warrant liabilities	5,715,000
Gain on marketable securities (net), dividends and interest, held in Trust Account	(53,369)
Changes in operating assets and liabilities:
Prepaid expenses	58,741
Accounts payable	(536,933)
Accrued expenses	3,037,776
Franchise tax payable	41,918
Net cash used in operating activities	(1,694,569)
Cash Flows from Financing Activities:
Proceeds from advances from related party	125,000
Net cash provided by financing activities	125,000
Net decrease in cash	(1,569,569)
Cash - beginning of the period	1,569,739
Cash - end of the period	170
Supplemental disclosure of noncash activities:
Change value of Class A common stock subject to possible redemption	$ 9,957,700

Description of Organization and

Description of Organization and Business Operations	6 Months Ended
	Jun. 30, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Description of Organization and Business Operations	Note 1—Description of Organization and Business Operations dMY Technology Group, Inc. III (the “Company”) is a blank check company incorporated in Delaware on September 14, 2020. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). The Company is an emerging growth company and, as such, the Company is subject to all of the risks associated with emerging growth companies. As of June 30, 2021, the Company had not commenced any operations. All activity for the period from September 14, 2020 (inception) to June 30, 2021 relates to the Company’s formation and the preparation of the initial public offering (the “Initial Public Offering”) and since the closing of the Initial Public Offering, the search for a prospective initial Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate non-operating The Company’s sponsor is dMY Sponsor III, LLC, a Delaware limited liability company (the “Sponsor”). The registration statement for the Company’s Initial Public Offering was declared effective on November 12, 2020. On November 17, 2020, the Company consummated its Initial Public Offering of 30,000,000 units (“Units” and, with respect to the Class A common stock included in the Units being offered, the “Public Shares”), including the 2,500,000 Units as a result of the underwriters’ partial exercise of their over-allotment option (“the Over-Allotment Units”), at $10.00 per Unit, generating gross proceeds of $300.0 million, and incurring offering costs of approximately $17.0 million, inclusive of $10.5 million in deferred underwriting commissions (Note 5). Simultaneously with the closing of the Initial Public Offering, the Company consummated the private placement (“Private Placement”) of 4,000,000 warrants at a price of $2.00 per warrant (“Private Placement Warrants”) to the Sponsor, generating gross proceeds of $8.0 million (Note 4). Upon the closing of the Initial Public Offering and the Private Placement, $300.0 million ($10.00 per Unit) of the net proceeds of the Initial Public Offering and certain of the proceeds of the Private Placement were placed in a trust account (“Trust Account”) located in the United States with Continental Stock Transfer & Trust Company acting as trustee, and invested only in United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act 1940, as amended (the “Investment Company Act”) having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete one or more initial Business Combinations having an aggregate fair market value of at least 80% of the net assets held in the Trust Account (net of amounts disbursed to management for working capital purposes, if permitted, and excluding the amount of any deferred underwriting commissions) at the time of the agreement to enter into the initial Business Combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. The Company will provide the holders (the “Public Stockholders”) of the Company’s outstanding shares of Class A common stock, par value $0.0001 per share, sold in the Initial Public Offering (the “Public Shares”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Public Stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then held in the Trust Account (initially at $10.00 per Public Share). The per-share Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (as discussed in Note 5). These Public Shares are recorded at a redemption value and classified as temporary equity in accordance with the Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” The Company will proceed with a Business Combination if a majority of the shares voted are voted in favor of the Business Combination. The Company will not redeem the Public Shares in an amount that would cause its net tangible assets to be less than $5,000,001. If a stockholder vote is not required by law and the Company does not decide to hold a stockholder vote for business or other legal reasons, the Company will, pursuant to its Certificate of Incorporation (the “Certificate of Incorporation”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, stockholder approval of the transaction is required by law, or the Company decides to obtain stockholder approval for business or legal reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. Additionally, each public stockholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction. If the Company seeks stockholder approval in connection with a Business Combination, the initial stockholders (as defined below) have agreed to vote their Founder Shares (as defined below in Note 4) and any Public Shares purchased during or after the Initial Public Offering in favor of a Business Combination. In addition, the initial stockholders have agreed to waive their redemption rights with respect to their Founder Shares and Public Shares in connection with the completion of a Business Combination. The Certificate of Incorporation provides that a public stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 20% or more of the Public Shares, without the prior consent of the Company. The Sponsor and the Company’s officers and directors (the “initial stockholders”) have agreed not to propose an amendment to the Certificate of Incorporation to modify the substance or timing of the Company’s obligation to redeem 100% of the Public Shares if the Company does not complete a Business Combination within the Combination Period (as defined below) or with respect to any other material provisions relating to stockholders’ rights or pre-initial If the Company is unable to complete a Business Combination within 24 months from the closing of the Initial Public Offering, or November 17, 2022 (the “Combination Period”), the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share The initial stockholders agreed to waive their rights to liquidating distributions from the Trust Account with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the initial stockholders acquire Public Shares in or after the Initial Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to the deferred underwriting commission (see Note 5) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be only $10.00. In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a third party (except for the Company’s independent registered public accounting firm) for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a letter of intent, confidentiality or other similar agreement or business combination agreement (a “Target”), reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.00 per Public Share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or Target that executed a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable) not will it apply to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except for the Company’s Independent Registered Public Accounting Firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. Proposed Business Combination On March 7, 2021, the Company entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Ion Trap Acquisition Inc., a Delaware corporation and a direct, newly formed wholly owned subsidiary of the Company (“Merger Sub”) and IonQ, Inc., a Delaware corporation (“IonQ”). Pursuant to the Merger Agreement, at the Effective Time, and in accordance with the Delaware General Corporation Law, as amended, Merger Sub will merge with and into IonQ (the “Merger”), with IonQ continuing as the surviving entity in the Merger and, after giving effect to the Merger, becoming a wholly owned subsidiary of the Company. See the Current Report on Form 8-K, On March 7, 2021, concurrently with the execution of the Merger Agreement, the Company entered into subscription agreements with certain investors (collectively, the “PIPE Investors”), pursuant to, and on the terms and subject to the conditions of which, the PIPE Investors have collectively subscribed for 35,000,000 shares of the Company’s Class A common stock for an aggregate purchase price equal to $350,000,000. See the Current Report on Form 8-K, Going Concern Consideration As of June 30, 2021, the Company had approximately $200 in its operating bank account, approximately $84,000 of interest income available in the Trust Account to pay for taxes and working capital deficiency of approximately $3.3 million. Further, the Company has incurred and expect to continue to incur significant costs in pursuit of its acquisition plans. Prior to the consummation of the Initial Public Offering, the Company’s liquidity needs had been satisfied through a capital contribution of $25,000 from the Sponsor to purchase the Founder Shares (as defined below), the loan under the Note from the Sponsor of approximately $121,000 (see Note 4). On December 21, 2020, the Company repaid approximately $90,000 of the outstanding Note balance. Subsequent to the consummation of the Initial Public Offering, the Company’s liquidity needs had been satisfied through the net proceeds from the consummation of the Private Placement not held in the Trust Account, and advances from an officer of $125,000. As of June 30 and $31,000 , respectively . 1 and December 31, 2020, there were no amounts outstanding under any Working Capital Loans. Based on the foregoing, management determines that the Company will not have sufficient working capital to meet its needs through the earlier of the consummation of a Business Combination or one year from this filing. The accompanying unaudited condensed consolidated financial statements have been prepared assuming the Company will continue as a going concern, which contemplates, among other things, the realization of assets and satisfaction of liabilities in the normal course of business. The Company plans to satisfy its working capital needs through the consummation of the initial Business Combination. However, there is no guarantee that the Company will complete its Business Combination within the Combination Period.

Basis of Presentation and Summa

Basis of Presentation and Summary of Significant Accounting Policies	6 Months Ended
	Jun. 30, 2021
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Note 2—Basis of Presentation and Summary of Significant Accounting Policies Basis of Presentation The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in accordance with United States generally accepted accounting principles (“GAAP”) for interim financial information and Regulation S-X. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the Company’s Annual Report on Amended Form 10-K/A Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging This may make comparison of the Company’s financial statements with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Use of Estimates The preparation of unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these financial statements is the determination of the fair value of the warrant liabilities. Actual results could differ from those estimates. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of June 30, 2021 and December 31, 2020. Concentration of Credit Risk Financial instruments that potentially subject the Company to concentration of credit risk consist of cash accounts in a financial institution which, at times, may exceed the Federal Depository Insurance Coverage of $ coverage limit, and investments held in Trust Account. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. Investments Held in the Trust Account The Company’s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company’s investments held in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company’s investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in income on investments held in the Trust Account in the accompanying unaudited condensed consolidated statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information. Offering Costs Associated with the Initial Public Offering The Company complies with the requirements of the ASC Topic 340-10-S99-1 was for offering costs associated with derivative warrant liabilities in th e statement of operations and approximately $ million is included in stockholders’ equity in the condensed consolidated balance sheets. Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC 820, “Fair Value Measurements” approximates the carrying amounts represented in the condensed consolidated balance sheets. Fair Value Measurements Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: • Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; • Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and • Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. As of June 30, 2021 and December 31, 2020, the carrying values of cash, accounts payable, accrued expenses franchise tax payable, and note payable to related parties approximate their fair values due to the short-term nature of the instruments. The Company’s investments held in Trust Account are comprised of investments in U.S. Treasury securities with an original maturity of 185 days. The fair value of investments held in Trust Account is determined using quoted prices in active markets. Derivative Financial Instruments The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “Derivatives and Hedging.” For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued non-current Class A Common Stock Subject to Possible Redemption The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Shares of Class A common stock subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Shares of conditionally redeemable Class A common stock (including Class A common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, shares of Class A common stock are classified as stockholders’ equity. The Company’s Class A common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, as of June 30, 2021 and December 31, 2020, 24,057,543 and 25,053,313 shares of Class A common stock subject to possible redemption are presented as temporary equity, outside of the stockholders’ equity section of the Company’s condensed consolidated balance sheets, respectively. Net Loss Per Share of Common Stock The Company’s condensed consolidated statements of operations include a presentation of net loss per share for Class A common stock subject to possible redemption in a manner similar to the two-class The calculation of diluted net loss per common stock does not consider the effect of the warrants issued in connection with the (i) Initial Public Offering, and (ii) Private Placement since the exercise price of the warrants is in excess of the average common stock price for the periods and therefore the inclusion of such warrants would be anti-dilutive. The following table reflects the calculation of basic and diluted net loss per share of common stock: For the Three Months For the Six Months Class A common stock Numerator: Income allocable to Class A common stock Income from investments held in Trust Account $ 6,545 $ 53,369 Less: Company’s portion available to be withdrawn to pay taxes (6,545 ) (53,369 ) Net income attributable to Class A common stock $ — $ — Denominator: Weighted average Class A common stock Basic and diluted weighted average shares outstanding, Class A common stock 30,000,000 30,000,000 Basic and diluted net income per share, Class A common stock $ — $ — Class B common stock Numerator: Net loss minus net income attributable to Class A common stock Net loss $ $ Net income attributable to Class A common stock — — Net loss attributable to Class B common stock $ $ Denominator: Weighted average Class B common stock Basic and diluted weighted average shares outstanding, Class B common stock 7,500,000 7,500,000 Basic and diluted net loss per share, Class B common stock $ (1.06 ) $ (1.33 ) Income Taxes The Company complies with the accounting and reporting requirements of Financial Accounting Standards Board Accounting Standard Codification, or ASC Topic 740, “Income Taxes,” which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not Recent Accounting Pronouncements The Company’s management does not believe that any recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying financial statements.

Initial Public Offering

Initial Public Offering	6 Months Ended
	Jun. 30, 2021
Equity [Abstract]
Initial Public Offering	Note 3 — Initial Public Offering On November 17, 2020, the Company consummated its Initial Public Offering of 30,000,000 Units, including the 2,500,000 Over-Allotment Units, at $10.00 per Unit, generating gross proceeds of $300.0 million, and incurring offering costs of approximately $17.0 million, inclusive of $10.5 million in deferred underwriting commissions. Each Unit consists of one share of Class A common stock, and one-fourth

Related Party Transactions

Related Party Transactions	6 Months Ended
	Jun. 30, 2021
Related Party Transactions [Abstract]
Related Party Transactions	Note 4 — Related Party Transactions Founder Shares On September 14, 2020, the Sponsor subscribed for 7,187,500 shares of the Company’s Class B common stock, par value $0.0001 per share, (the “Founder Shares”) for a total subscription price of $25,000, and fully paid for these on November 17, 2020. In October 2020, the Sponsor transferred 25,000 Founder Shares to each of Darla Anderson, Francesca Luthi and Charles E. Wert, the Company’s director nominees. On November 12, 2020, the Company effected a 1:1.1 stock split of the Class B common stock, resulting in an aggregate of 7,906,250 shares outstanding. All shares and associated amounts have been retroactively restated to reflect the stock split. The initial stockholders agreed to forfeit up to 1,031,250 Founder Shares to the extent that the over-allotment option is not exercised in full by the underwriters, so that the Founder Shares will represent 20.0% of the Company’s issued and outstanding shares after the Initial Public Offering. On November 17, 2020, the underwriters partially exercised their over-allotment option to purchase 2,500,000 units resulting in 625,000 shares of Class B common stock no longer being subject to forfeiture. The over-allotment option expired on December 27, 2020, resulting in 406,250 shares of Class B common stock being forfeited. The initial stockholders agreed, subject to limited exceptions, not to transfer, assign or sell any of the Founder Shares until the earlier to occur of: (A) one year after the completion of the initial Business Combination or earlier if, subsequent to the initial Business Combination, the closing price of the Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading Private Placement Warrants Simultaneously with the closing of the Initial Public Offering, the Company consummated the Private Placement of 4,000,000 Private Placement Warrants at a price of $2.00 per Private Placement Warrant to the Sponsor, generating gross proceeds of $8.0 million. Each whole Private Placement Warrant is exercisable for one whole share of Class A common stock at a price of $11.50 per share. A portion of the proceeds from the sale of the Private Placement Warrants to the Sponsor was added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the Private Placement Warrants will expire worthless. The Private Placement Warrants will be non-redeemable The Sponsor and the Company’s officers and directors agreed, subject to limited exceptions, not to transfer, assign or sell any of their Private Placement Warrants until 30 days after the completion of the initial Business Combination. Related Party Loans On September 14, 2020, the Sponsor agreed to loan the Company an aggregate of up to $200,000 to cover expenses related to the Initial Public Offering pursuant to a promissory note (the “Note”). This loan was non-interest and is included in due to related parties on the condensed balance sheets. In April and June 2021, the Company received advances for an aggregate amount of $ from an officer for working capital needs, which is included in due In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination or, at the lender’s discretion, up to $1.5 million of such Working Capital Loans may be convertible into warrants of the post Business Combination entity at a price of $2.00 per warrant. The warrants would be identical to the Private Placement Warrants. As of June 30, 2021 and December 31, 2020, the Company had no borrowings under the Working Capital Loans. Administrative Services Agreement The Company entered into an agreement that will provide that, commencing on the date that the Company’s securities are first listed on New York Stock Exchange and continuing until the earlier of the Company’s consummation of a Business Combination and the Company’s liquidation, the Company agreed to pay the Sponsor a total of $10,000 per month for office space, secretarial and administrative services provided to members of the Company’s management team. For the three and six months ended June 30, 2021, the Company incurred $30,000 and $60,000, respectively, in connection with such services in the accompanying unaudited condensed consolidated s consolidated The Sponsor, executive officers and directors, or any of their respective affiliates will be reimbursed for any out-of-pocket

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Jun. 30, 2021
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Note 5 — Commitments and Contingencies Registration Rights The holders of Founder Shares, Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans, if any, (and any shares of Class A common stock issuable upon the exercise of the Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans and upon conversion of the Founder Shares) are entitled to registration rights pursuant to a registration rights agreement. These holders will be entitled to certain demand and “piggyback” registration rights. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The underwriters were entitled to underwriting commissions of $0.20 per unit, or $6.00 million in the aggregate, paid upon the closing of the Initial Public Offering. In addition, $0.35 per unit, or approximately $10.5 million in the aggregate will be payable to the underwriters for deferred underwriting commissions. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement. Litigation On January 12, 2021, the Company, the Sponsor accepted service of a lawsuit where they are named as Counterclaim Defendants in an underlying action by and between GTY Technology Holdings, Inc. (“GTY”), dMY Technology Holdings Inc., dMY Sponsor, LLC, dMY Sponsor II, LLC, dMY Technology Group Inc. II, the Company and the Sponsor (collectively “dMY”) and Carter Glatt (“Glatt”) and Captains Neck Holdings LLC (“Captains Neck”). The Underlying Lawsuit seeks a declaratory judgment that Glatt and Captains Neck are not entitled to Class Y Units of dMY Sponsor LLC and contains claims arising from Glatt’s termination of employment from GTY on or about April 3, 2020 including theft and misappropriation of confidential GTY information, breach of contract, breach of the duties of loyalty and fiduciary duty and conversion. Glatt has, among other things, responded to the Underlying Lawsuit by adding members of the Sponsor and officers of the Company as Counterclaim Defendants and adding Dune Acquisition Holdings LLC, a newly formed special purpose acquisition company as a Counterclaimant and asserting claims for breach of contract, fraudulent misrepresentation, negligent misrepresentation, tortious interference with business relations, quantum meruit and unjust enrichment. The Company has never employed Glatt and has no business agreements with him. The Company has denied the claims against them and management intends to vigorously defend the Company. Risk and Uncertainties On January 30, 2020, the World Health Organization (“WHO”) announced a global health emergency because of a new strain of coronavirus (the “COVID-19 COVID-19 COVID-19 COVID-19 COVID-19 COVID-19 COVID-19

Stockholders' Equity

Stockholders' Equity	6 Months Ended
	Jun. 30, 2021
Equity [Abstract]
Stockholders' Equity	Note 6 — Stockholders’ Equity Class A Common Stock consolidated Class B Common Stock Stockholders of record are entitled to one vote for each share held on all matters to be voted on by stockholders. Holders of Class A common stock and holders of Class B common stock will vote together as a single class on all matters submitted to a vote of our stockholders except as required by law. The Class B common stock will automatically convert into Class A common stock concurrently with or immediately following the consummation of the initial Business Combination on a one-for-one as-converted one-for-one Preferred Stock

Derivative Warrant Liabilities

Derivative Warrant Liabilities	6 Months Ended
	Jun. 30, 2021
Derivate Warrant Liabilities [Abstract]
Derivative Warrant Liabilities	Note 7 — Derivative Warrant Liabilities As of June 30, 2021 and December 31, 2020, the Company has 7,500,000 and 4,000,000 Public Warrants and Private Placement Warrants, respectively, outstanding. Public Warrants may only be exercised for a whole number of shares. No fractional Public Warrants will be issued upon separation of the Units and only whole Public Warrants will trade. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination or (b) 12 months from the closing of the Initial Public Offering; provided in each case that the Company has an effective registration statement under the Securities Act covering the shares of Class A common stock issuable upon exercise of the Public Warrants and a current prospectus relating to them is available (or the Company permits holders to exercise their Public Warrants on a cashless basis and such cashless exercise is exempt from registration under the Securities Act). The Company has agreed that as soon as practicable, but in no event later than 15 business days after the closing of the initial Business Combination, the Company will use its best efforts to file with the SEC and have an effective registration statement covering the shares of Class A common stock issuable upon exercise of the warrants and to maintain a current prospectus relating to those shares of Class A common stock until the warrants expire or are redeemed. If a registration statement covering the Class A common stock issuable upon exercise of the warrants is not effective by the 60th business day after the closing of the initial Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. Notwithstanding the above, if the Company’s shares of Class A common stock are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elect, it will not be required to file or maintain in effect a registration statement, and in the event the Company does not so elect, it will use our best efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. The warrants have an exercise price of $11.50 per share, subject to adjustments and will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation. In addition, if (x) the Company issues additional shares of Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per share of Class A common stock (with such issue price or effective issue price to be determined in good faith by the board of directors and, in the case of any such issuance to the initial stockholders or their affiliates, without taking into account any Founder Shares held by the initial stockholders or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the consummation of the initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of our Class A common stock during the 20 trading day period starting on the trading day after the day on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, the $18.00 per share redemption trigger price described under “Redemption of warrants when the price per share of Class A common stock equals or exceeds $18.00” will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price, and the $10.00 per share redemption trigger price described under “Redemption of warrants when the price per share of Class A common Stock equals or exceeds $10.00” will be adjusted (to the nearest cent) to be equal to the higher of the Market Value and the Newly Issued Price. The Private Placement Warrants are identical to the Public Warrants, except that the Private Placement Warrants and the shares of Class A common stock issuable upon exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will be non-redeemable Redemption of warrants when the price per share of Class A common stock equals or exceeds $18.00 Once the warrants become exercisable, the Company may redeem the outstanding warrants for cash: • in whole and not in part; • at a price of $0.01 per warrant; • upon a minimum of 30 days’ prior written notice of redemption; and • if, and only if, the closing price of Class A common stock equals or exceeds $18.00 per share (as adjusted) for any 20 trading days within a 30-trading The Company will not redeem the warrants as described above unless an effective registration statement under the Securities Act covering the Class A common stock issuable upon exercise of the warrants is effective and a current prospectus relating to those shares of Class A common stock is available throughout the 30-day Redemption of warrants for when the price per share of Class A common stock equals or exceeds $10.00 Once the warrants become exercisable, the Company may redeem the outstanding warrants: • in whole and not in part; • at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined by reference to an agreed table based on the redemption date and the “fair market value” (as defined below) of the Class A common stock; and • if, and only if, the closing price of Class A common stock equals or exceeds $10.00 per Public Share (as adjusted) for any 20 trading days within the 30-trading The “fair market value” of Class A common stock shall mean the volume weighted average price of Class A common stock during the 10 trading days immediately following the date on which the notice of redemption is sent to the holders of warrants. In no event will the warrants be exercisable in connection with this redemption feature for more than 0.361 shares of Class A common stock per warrant (subject to adjustment). If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless.

Fair Value Measurements

Fair Value Measurements	6 Months Ended
	Jun. 30, 2021
Fair Value Disclosures [Abstract]
Fair Value Measurements	Note 8 - Fair Value Measurements The fair value of the Public Warrants issued in connection with the Public Offering and Private Placement Warrants were initially measured at fair value using a Monte Carlo simulation model and subsequently, the fair value of the Private Placement Warrants have been estimated using a Black-Scholes simulation model each measurement date. The fair value of Public Warrants issued in connection with the Initial Public Offering have been measured based on the listed market price of such warrants since October 2020. For the three and six months ended June 30, 2021, the Company recognized a charge to the accompanying unaudited condensed consolidated statements of operations resulting from an increase of in the fair value of liabilities of approximately $7.5 million and approximately $5.7 million presented as change in fair value of derivative warrant liabilities in the accompanying unaudited condensed consolidated statements of operations, respectively. The following table presents information about the Company’s consolidated financial assets that are measured at fair value on a recurring basis as of June 30, 2021 and December 31, 2020 by level within the fair value hierarchy: June 30, 2021 Description Quoted Markets (Level 1) Significant Other Observable Inputs (Level 2) Significant Other Unobservable Inputs (Level 3) Assets: Investments held in Trust Account - U.S. Treasury Securities (1) $ 300,083,544 $ — $ — Liabilities: Derivative warrant liabilities $ 24,000,000 $ — $ 16,600,000 (1) Excludes $390 of cash balance held within the Trust Account. December 31, 2020 Description Quoted in Active Markets (Level 1) Significant Other Observable Inputs (Level 2) Significant Other Unobservable Inputs (Level 3) Assets: Investments held in Trust Account - U.S. Treasury Securities (1) $ 300,029,996 $ — $ — Liabilities: Derivative warrant liabilities $ — $ — $ 34,885,000 (1) Excludes $569 of cash balance held within the Trust Account. Transfers to/from Levels 1, 2 and 3 are recognized at the beginning of the reporting period. The estimated fair value of the Public Warrants transferred from a Level 3 measurement to a Level 1 fair value measurement in January 2021, when the Public Warrants were separately listed and traded. As of June 30, 2021, the Public Warrants were publicly traded at $3.20 per warrant. The estimated fair value of the Private Placement Warrants, and the Public Warrants prior to being separately listed and traded, is determined using Level 3 inputs. Inherent in a Monte Carlo simulation are assumptions related to expected stock-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the volatility of its common stock warrants based on implied volatility from the Company’s traded warrants and from historical volatility of select peer company’s common stock that matches the expected remaining life of the warrants. The risk-free interest rate is based on the U.S. Treasury zero-coupon The following table provides quantitative information regarding Level 3 fair value measurements inputs as their measurement dates: As of December 31, 2020 As of June 30, 2021 Exercise price $ 11.50 $ 11.50 Stock price $ 10.84 $ 10.69 Volatility 22.7% / 40.5% / Term 6.42 5.25 Risk-free rate 0.57 % 0.91 % Dividend yield 0.0 % 0.0 % The change in the fair value of the derivative warrant lia b Level 3 - Derivative warrant liabilities at December 31, 2020 $ 34,885,000 Transfer to Level 1 (16,725,000 ) Change in fair value of derivative warrant liabilities (1,560,000 ) Level 3 - Derivative warrant liabilities at June 30, 2021 $ 16,600,000

Subsequent Events

Subsequent Events	6 Months Ended
	Jun. 30, 2021
Subsequent Events [Abstract]
Subsequent Events	Note 9 - Subsequent Events The Company evaluated subsequent events and transactions that occurred after June 30, 2021 up to the date that the unaudited condensed consolidated financial statements were available to be issued, and determined that there have been no other events that have occurred that would require adjustments to the disclosures in the unaudited condensed consolidated financial statements.

Basis of Presentation and Sum_2

Basis of Presentation and Summary of Significant Accounting Policies (Policies)	6 Months Ended
	Jun. 30, 2021
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in accordance with United States generally accepted accounting principles (“GAAP”) for interim financial information and Regulation S-X. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the Company’s Annual Report on Amended Form 10-K/A
Emerging Growth Company	Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging This may make comparison of the Company’s financial statements with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Use of Estimates	Use of Estimates The preparation of unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these financial statements is the determination of the fair value of the warrant liabilities. Actual results could differ from those estimates.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of June 30, 2021 and December 31, 2020.
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentration of credit risk consist of cash accounts in a financial institution which, at times, may exceed the Federal Depository Insurance Coverage of $ coverage limit, and investments held in Trust Account. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.
Investments Held in Trust Account	Investments Held in the Trust Account The Company’s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company’s investments held in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company’s investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in income on investments held in the Trust Account in the accompanying unaudited condensed consolidated statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information.
Offering Costs Associated with the Initial Public Offering	Offering Costs Associated with the Initial Public Offering The Company complies with the requirements of the ASC Topic 340-10-S99-1 was for offering costs associated with derivative warrant liabilities in th e statement of operations and approximately $ million is included in stockholders’ equity in the condensed consolidated balance sheets.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC 820, “Fair Value Measurements” approximates the carrying amounts represented in the condensed consolidated balance sheets.
Fair Value Measurements	Fair Value Measurements Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: • Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; • Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and • Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. As of June 30, 2021 and December 31, 2020, the carrying values of cash, accounts payable, accrued expenses franchise tax payable, and note payable to related parties approximate their fair values due to the short-term nature of the instruments. The Company’s investments held in Trust Account are comprised of investments in U.S. Treasury securities with an original maturity of 185 days. The fair value of investments held in Trust Account is determined using quoted prices in active markets.
Derivative Financial Instruments	Derivative Financial Instruments The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “Derivatives and Hedging.” For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued non-current
Class A Common Stock Subject to Possible Redemption	Class A Common Stock Subject to Possible Redemption The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Shares of Class A common stock subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Shares of conditionally redeemable Class A common stock (including Class A common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, shares of Class A common stock are classified as stockholders’ equity. The Company’s Class A common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, as of June 30, 2021 and December 31, 2020, 24,057,543 and 25,053,313 shares of Class A common stock subject to possible redemption are presented as temporary equity, outside of the stockholders’ equity section of the Company’s condensed consolidated balance sheets, respectively.
Net Loss Per Share of Common Stock	Net Loss Per Share of Common Stock The Company’s condensed consolidated statements of operations include a presentation of net loss per share for Class A common stock subject to possible redemption in a manner similar to the two-class The calculation of diluted net loss per common stock does not consider the effect of the warrants issued in connection with the (i) Initial Public Offering, and (ii) Private Placement since the exercise price of the warrants is in excess of the average common stock price for the periods and therefore the inclusion of such warrants would be anti-dilutive. The following table reflects the calculation of basic and diluted net loss per share of common stock: For the Three Months For the Six Months Class A common stock Numerator: Income allocable to Class A common stock Income from investments held in Trust Account $ 6,545 $ 53,369 Less: Company’s portion available to be withdrawn to pay taxes (6,545 ) (53,369 ) Net income attributable to Class A common stock $ — $ — Denominator: Weighted average Class A common stock Basic and diluted weighted average shares outstanding, Class A common stock 30,000,000 30,000,000 Basic and diluted net income per share, Class A common stock $ — $ — Class B common stock Numerator: Net loss minus net income attributable to Class A common stock Net loss $ $ Net income attributable to Class A common stock — — Net loss attributable to Class B common stock $ $ Denominator: Weighted average Class B common stock Basic and diluted weighted average shares outstanding, Class B common stock 7,500,000 7,500,000 Basic and diluted net loss per share, Class B common stock $ (1.06 ) $ (1.33 )
Recent Accounting Pronouncements	Recent Accounting Pronouncements The Company’s management does not believe that any recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying financial statements.
Income Taxes	Income Taxes The Company complies with the accounting and reporting requirements of Financial Accounting Standards Board Accounting Standard Codification, or ASC Topic 740, “Income Taxes,” which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. more-likely-than-not

Basis of Presentation and Sum_3

Basis of Presentation and Summary of Significant Accounting Policies - (Table)	6 Months Ended
	Jun. 30, 2021
Accounting Policies [Abstract]
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	The following table reflects the calculation of basic and diluted net loss per share of common stock: For the Three Months For the Six Months Class A common stock Numerator: Income allocable to Class A common stock Income from investments held in Trust Account $ 6,545 $ 53,369 Less: Company’s portion available to be withdrawn to pay taxes (6,545 ) (53,369 ) Net income attributable to Class A common stock $ — $ — Denominator: Weighted average Class A common stock Basic and diluted weighted average shares outstanding, Class A common stock 30,000,000 30,000,000 Basic and diluted net income per share, Class A common stock $ — $ — Class B common stock Numerator: Net loss minus net income attributable to Class A common stock Net loss $ $ Net income attributable to Class A common stock — — Net loss attributable to Class B common stock $ $ Denominator: Weighted average Class B common stock Basic and diluted weighted average shares outstanding, Class B common stock 7,500,000 7,500,000 Basic and diluted net loss per share, Class B common stock $ (1.06 ) $ (1.33 )

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	6 Months Ended
	Jun. 30, 2021
Fair Value Disclosures [Abstract]
Summary of financial Asset measured at fair value on recurring basis	The following table presents information about the Company’s consolidated financial assets that are measured at fair value on a recurring basis as of June 30, 2021 and December 31, 2020 by level within the fair value hierarchy: June 30, 2021 Description Quoted Markets (Level 1) Significant Other Observable Inputs (Level 2) Significant Other Unobservable Inputs (Level 3) Assets: Investments held in Trust Account - U.S. Treasury Securities (1) $ 300,083,544 $ — $ — Liabilities: Derivative warrant liabilities $ 24,000,000 $ — $ 16,600,000 (1) Excludes $390 of cash balance held within the Trust Account. December 31, 2020 Description Quoted in Active Markets (Level 1) Significant Other Observable Inputs (Level 2) Significant Other Unobservable Inputs (Level 3) Assets: Investments held in Trust Account - U.S. Treasury Securities (1) $ 300,029,996 $ — $ — Liabilities: Derivative warrant liabilities $ — $ — $ 34,885,000 (1) Excludes $569 of cash balance held within the Trust Account.
Summary of fair value measurements inputs	The following table provides quantitative information regarding Level 3 fair value measurements inputs as their measurement dates: As of December 31, 2020 As of June 30, 2021 Exercise price $ 11.50 $ 11.50 Stock price $ 10.84 $ 10.69 Volatility 22.7% / 40.5% / Term 6.42 5.25 Risk-free rate 0.57 % 0.91 % Dividend yield 0.0 % 0.0 %
Summary of change in the fair value of the derivative warrant liabilities	The change in the fair value of the derivative warrant lia b Level 3 - Derivative warrant liabilities at December 31, 2020 $ 34,885,000 Transfer to Level 1 (16,725,000 ) Change in fair value of derivative warrant liabilities (1,560,000 ) Level 3 - Derivative warrant liabilities at June 30, 2021 $ 16,600,000

Description of Organization a_2

Description of Organization and Business Operations - Additional Information (Detail) - USD ($)	Mar. 07, 2021	Dec. 21, 2020	Nov. 17, 2020	Sep. 14, 2020	Nov. 17, 2020	Jun. 30, 2021	Dec. 31, 2020
Organization Business And Basis Of Presentation [Line Items]
Initial Public Offering, units			30,000,000
Initial Public Offering, price per unit			$ 10		$ 10
Initial Public Offering, gross proceeds			$ 300,000,000
Initial Public Offering, offering costs			17,000,000
Initial Public Offering, deferred underwriting commissions			$ 10,500,000		$ 10,500,000
Cash						$ 170	$ 1,569,739
Business Combination within in the Combination Period, possible per share value of residual assets remaining available for distribution						$ 10
Business Combination required completion period after Initial Public Offering						24 months
Repayments of Notes Payable						$ 90,000
Liquidity and Capital Resources [Member]
Organization Business And Basis Of Presentation [Line Items]
Cash						200
Net Working Capital						3,300,000
Interest income held in Trust account						$ 84,000
Common Class A [Member]
Organization Business And Basis Of Presentation [Line Items]
Initial Public Offering, price per unit			$ 11.50		$ 11.50
Common stock, par value						$ 0.0001	$ 0.0001
Common stock, price per public share						$ 10
Common Class A [Member] | Ion Trap Acquisition Inc [Member]
Organization Business And Basis Of Presentation [Line Items]
Initial Public Offering, units	35,000,000
Stock Issued During Period, Value, New Issues	$ 350,000,000
Maximum [Member]
Organization Business And Basis Of Presentation [Line Items]
Business Combination, maximum amount of interest to pay dissolution expenses						$ 100,000
Percentage of aggregate Public Shares restricted from redeem						20.00%
Public Shares redeemable amount limit of net tangible assets						$ 5,000,001
Trust Account [Member]
Organization Business And Basis Of Presentation [Line Items]
Initial Public Offering, price per unit			$ 10		$ 10
Initial Public Offering, gross proceeds					$ 300,000,000
Underwriters Over Allotment [Member]
Organization Business And Basis Of Presentation [Line Items]
Initial Public Offering, units			2,500,000
Private Placement [Member]
Organization Business And Basis Of Presentation [Line Items]
Initial Public Offering, units			4,000,000
Initial Public Offering, price per unit			$ 2		$ 2
Initial Public Offering, private placement gross proceeds			$ 8,000,000
Sponsor [Member]
Organization Business And Basis Of Presentation [Line Items]
Contribution from the sponsor						25,000
Proceeds from notes payable to related party current		$ 125,000				121,000
Repayments of Notes Payable		90,000
Proceeds from Notes Payable		$ 125,000				121,000
Due to Related Parties						$ 156,000	$ 31,000
Sponsor [Member] | Maximum [Member]
Organization Business And Basis Of Presentation [Line Items]
Proceeds from notes payable to related party current				$ 200,000
Proceeds from Notes Payable				$ 200,000

Basis of Presentation and Sum_4

Basis of Presentation and Summary of Significant Accounting Policies - Schedule of Earnings Per Share, Basic and Diluted (Detail) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Mar. 31, 2021	Jun. 30, 2021
Numerator: Net Loss Minus Net Income Attributable To Class A Common Stock
Net loss			$ (9,957,702)
Net loss attributable to Class B common stock	$ (7,930,260)	$ (2,027,442)	(9,957,702)
Common Class A [Member]
Numerator: Income allocable to Class A common stock
Income from investments held in Trust Account		6,545	53,369
Less: Company's portion available to be withdrawn to pay taxes		$ (6,545)	(53,369)
Net income attributable to Class A common stock	$ 0		$ 0
Denominator: Weighted average Class A common stock
Weighted Average Number of Shares Outstanding, Basic and Diluted	30,000,000	30,000,000	30,000,000
Basic and diluted net income per share, Class A common stock	$ 0		$ 0
Numerator: Net Loss Minus Net Income Attributable To Class A Common Stock
Net income attributable to Class A common stock	$ 0		$ 0
Denominator: Weighted average Class B common stock
Basic and diluted weighted average shares outstanding, Class B common stock	30,000,000	30,000,000	30,000,000
Basic and diluted net loss per share, Class B common stock	$ 0		$ 0
Common Class B [Member]
Numerator: Income allocable to Class A common stock
Net income attributable to Class A common stock	$ 0		$ 0
Denominator: Weighted average Class A common stock
Weighted Average Number of Shares Outstanding, Basic and Diluted	7,500,000	7,500,000	7,500,000
Basic and diluted net income per share, Class A common stock	$ (1.06)	$ (1.06)	$ (1.33)
Numerator: Net Loss Minus Net Income Attributable To Class A Common Stock
Net loss	$ (7,930,260)		$ (9,957,702)
Net income attributable to Class A common stock	$ 0		0
Net loss attributable to Class B common stock		$ (7,930,260)	$ (9,957,702)
Denominator: Weighted average Class B common stock
Basic and diluted weighted average shares outstanding, Class B common stock	7,500,000	7,500,000	7,500,000
Basic and diluted net loss per share, Class B common stock	$ (1.06)	$ (1.06)	$ (1.33)

Basis of Presentation and Sum_5

Basis of Presentation and Summary of Significant Accounting Policies - Additional Information (Detail) - USD ($)	6 Months Ended	12 Months Ended
	Jun. 30, 2021	Dec. 31, 2020
Significant Accounting Policies [Line Items]
Federal depository insurance coverage limit	$ 250,000
Cash equivalents	$ 0	$ 0
Restricted investments maturity	185 days
IPO [Member]
Significant Accounting Policies [Line Items]
Financing cost attributable to derivative warrant liabilities	$ 700,000
Adjustments to additional paid in capital, stock issued, issuance costs	16,300,000
Class A Shares [Member]
Significant Accounting Policies [Line Items]
Temporary equity, accretion to redemption value	$ 24,057,543	$ 25,053,313

Initial Public Offering - Addit

Initial Public Offering - Additional Information (Detail) $ / shares in Units, $ in Millions	Nov. 17, 2020USD ($)$ / sharesshares
Initial Public Offering [Line Items]
Initial Public Offering, units | shares	30,000,000
Initial Public Offering, price per unit | $ / shares	$ 10
Initial Public Offering, gross proceeds	$ 300
Initial Public Offering, offering costs	17
Initial Public Offering, deferred underwriting commissions	$ 10.5
Class A Shares [Member]
Initial Public Offering [Line Items]
Initial Public Offering, price per unit | $ / shares	$ 11.50
IPO [Member]
Initial Public Offering [Line Items]
Initial Public Offering, units | shares	30,000,000
Initial Public Offering, price per unit | $ / shares	$ 10
Initial Public Offering, gross proceeds	$ 300
Initial Public Offering, offering costs	17
Initial Public Offering, deferred underwriting commissions	$ 10.5
Over-Allotment Option [Member]
Initial Public Offering [Line Items]
Initial Public Offering, units | shares	2,500,000

Related Party Transactions - Ad

Related Party Transactions - Additional Information (Detail) - USD ($)	Dec. 21, 2020	Nov. 17, 2020	Sep. 14, 2020	Oct. 31, 2020	Jun. 30, 2021	Dec. 31, 2020	Jun. 30, 2021	Dec. 27, 2020	Nov. 12, 2020	Aug. 18, 2020
Related Party Transaction [Line Items]
Initial Public Offering, units		30,000,000
Initial Public Offering, price per unit		$ 10
Repayments of Notes Payable							$ 90,000
Notes payable related parties					$ 31,000	$ 31,000	31,000
Underwriters Over Allotment [Member]
Related Party Transaction [Line Items]
Initial Public Offering, units		2,500,000
Founder Shares [Member]
Related Party Transaction [Line Items]
Initial stockholders agreed to forfeit						1,031,250
Percentage of founder shares from related party						20.00%
Founder Shares [Member] | Darla Anderson [Member]
Related Party Transaction [Line Items]
Shares transferred during the period				25,000
Founder Shares [Member] | Francesca Luthi [Member]
Related Party Transaction [Line Items]
Shares transferred during the period				25,000
Founder Shares [Member] | Charles E Wert [Member]
Related Party Transaction [Line Items]
Shares transferred during the period				25,000
Sponsor [Member]
Related Party Transaction [Line Items]
Repayments of Notes Payable	$ 90,000
Proceeds from notes payable to related party current	125,000						121,000
Proceeds from Notes Payable	$ 125,000						121,000
Sponsor [Member] | Maximum [Member]
Related Party Transaction [Line Items]
Proceeds from notes payable to related party current			$ 200,000
Proceeds from Notes Payable			$ 200,000
Related Party Loans [Member]
Related Party Transaction [Line Items]
Convertible price warrants for post business combination entity			$ 2
Related Party Loans [Member] | Maximum [Member]
Related Party Transaction [Line Items]
Proceeds from Promissory Note to related party							121,000
Working Capital Loans							1,500,000
Administrative Service Agreement [Member]
Related Party Transaction [Line Items]
Monthly charge for administrative services							10,000
Related Party Transaction, Amounts of Transaction					30,000		60,000
Prepaid Expense					160,000	$ 0	$ 160,000
Working Capital Loan [Member]
Related Party Transaction [Line Items]
Proceeds from notes payable to related party current					125,000
Proceeds from Notes Payable					$ 125,000
Private Placement Warrant [Member]
Related Party Transaction [Line Items]
Initial Public Offering, units							4,000,000
Initial Public Offering, price per unit					$ 2		$ 2
Initial Public Offering, gross proceeds							$ 8,000,000
Common Class A [Member]
Related Party Transaction [Line Items]
Initial Public Offering, price per unit		$ 11.50
Common stock, par value					$ 0.0001	$ 0.0001	$ 0.0001
Warrants exercise price per share										$ 11.50
Common stock, shares outstanding					5,942,457	4,946,687	5,942,457
Common Class A [Member] | Founder Shares [Member]
Related Party Transaction [Line Items]
Closing Share Threshold Price			$ 12
Common Class A [Member] | Private Placement Warrant [Member]
Related Party Transaction [Line Items]
Warrants exercise price per share					$ 11.50		$ 11.50
Common Class B [Member]
Related Party Transaction [Line Items]
Common stock, par value					$ 0.0001	$ 0.0001	$ 0.0001
Common stock, shares outstanding					7,500,000	7,500,000	7,500,000		7,906,250
Common stock that were subject to forfeiture		625,000						406,250
Common Class B [Member] | Founder Shares [Member]
Related Party Transaction [Line Items]
Offering costs for an aggregate price			$ 25,000
Initial Public Offering, units			7,187,500
Common stock, par value			$ 0.0001

Commitments & Contingencies - A

Commitments & Contingencies - Additional Information (Detail) $ / shares in Units, $ in Thousands	6 Months Ended
	Jun. 30, 2021USD ($)$ / shares
Underwriting discount | $ / shares	$ 0.20
Underwriting discount aggregate amount | $	$ 6,000
Additional fee per unit | $ / shares	$ 0.35
Deferred underwriting commissions in connection with the initial public offering | $	$ 10,500

Stockholders' Equity - Addition

Stockholders' Equity - Additional Information (Detail) - $ / shares	Nov. 17, 2020	Jun. 30, 2021	Mar. 31, 2021	Dec. 31, 2020	Dec. 27, 2020	Nov. 12, 2020
Class of Stock [Line Items]
Common stock voting right		Stockholders of record are entitled to one vote for each share held on all matters to be voted on by stockholders. Holders of Class A common stock and holders of Class B common stock will vote together as a single class on all matters submitted to a vote of our stockholders except as required by law.
Preferred stock, par or stated value per share		$ 0.0001		$ 0.0001
Preferred stock, shares authorized		1,000,000		1,000,000
Preferred stock, shares issued		0		0
Preferred stock, shares outstanding		0		0
Initial Public Offering, units	30,000,000
Over-Allotment Option [Member]
Class of Stock [Line Items]
Initial Public Offering, units	2,500,000
Class A Shares [Member]
Class of Stock [Line Items]
Common stock, shares authorized		380,000,000		380,000,000
Common stock, par value		$ 0.0001		$ 0.0001
Common stock, shares issued		5,942,457		4,946,687
Shares issued in the IPO		30,000,000		30,000,000
Common stock, shares outstanding		5,942,457		4,946,687
Common stock shares issuable upon conversion		the number of shares of Class A common stock issuable upon conversion of all Founder Shares will equal, in the aggregate, on an as-converted basis, 20% of the total number of shares of Class A common stock outstanding after such conversion (after giving effect to any redemptions of shares of Class A common stock by Public Stockholders)
Common stock subject to possible redemption		24,057,543		25,053,313
Class B Shares [Member]
Class of Stock [Line Items]
Common stock, shares authorized		20,000,000		20,000,000
Common stock, par value		$ 0.0001		$ 0.0001
Common stock, shares issued	7,187,500	7,500,000		7,500,000
Common stock, shares outstanding		7,500,000		7,500,000		7,906,250
Common stock shares issued including shares subject to forfeiture		1,031,250
Initial stockholders own Company's issued and outstanding common stock after the initial public offering			20.00%
Reverse stock split description		one-for-one basis, subject to adjustment for stock splits
Common stock shares no longer subject to forefeiture	625,000
Class B Shares [Member] | Over-Allotment Option [Member]
Class of Stock [Line Items]
Common stock shares no longer subject to forefeiture					406,250
Initial Public Offering, units	2,500,000

Derivative Warrant Liabilities

Derivative Warrant Liabilities - Additional Information (Detail) - $ / shares	Aug. 18, 2020	Jun. 30, 2021	Dec. 31, 2020
Public Warrants will become exercisable		on the later of (a) 30 days after the completion of a Business Combination or (b) 12 months from the closing of the Initial Public Offering
Public warrant for redemption price		at a price of $0.01 per warrant
Public warrants expire date		upon a minimum of 30 days’ prior written notice of redemption
Common Stock Price Equals To Or Exceeds Ten Dollars [Member]
Warrant redemption trigger price subject to adjustment		$ 10
Public Warrants [Member]
Number of warrants or rights outstanding		7,500,000	4,000,000
Exercise price per warrant		$ 3.20
Common Class A [Member]
Exercise price per warrant	$ 11.50
Common Class A [Member] | Redemption Price One [Member]
Number of days of notice to be given to warrant holders before redemption		30 days
Redemption price of warrants per unit	$ 0.01
Number of consecutive trading days for which the stock price is to be maintained		20 days
Number of trading days		30 days
Common Class A [Member] | Redemption Price Two [Member]
Number of days of notice to be given to warrant holders before redemption	30 days
Redemption price of warrants per unit	$ 0.10
Number of consecutive trading days for which the stock price is to be maintained		20 days
Number of trading days		30 days
Common Class A [Member] | Maximum [Member]
Issue price at closing of its initial business combination		$ 9.20
Number of shares of common stock excercisable per warrant	0.361
Common Class A [Member] | Minimum [Member]
Warrant exercise price, description		the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, the $18.00 per share redemption trigger price described under “Redemption of warrants when the price per share of Class A common stock equals or exceeds $18.00” will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price
The aggregate gross proceeds from such issuances		60.00%
Common Class A [Member] | Minimum [Member] | Redemption Price One [Member]
Share price	$ 18
Common Class A [Member] | Minimum [Member] | Redemption Price Two [Member]
Share price	$ 10

Fair Value Measurements - Summa

Fair Value Measurements - Summary of financial Asset measured at fair value on recurring basis (Detail) - USD ($)	Jun. 30, 2021		Dec. 31, 2020
Quoted Prices in Active Markets (Level 1) [Member]
Liabilities:
Derivative warrant liabilities	$ 24,000,000		$ 0
Quoted Prices in Active Markets (Level 1) [Member] | U.S. Treasury Securities [Member]
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Investments held in Trust Account	300,083,544	[1]	300,029,996	[2]
Significant Other Observable Inputs (Level 2) [Member]
Liabilities:
Derivative warrant liabilities	0		0
Significant Other Observable Inputs (Level 2) [Member] | U.S. Treasury Securities [Member]
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Investments held in Trust Account		[1]		[2]
Significant Other Unobservable Inputs (Level 3) [Member]
Liabilities:
Derivative warrant liabilities	16,600,000		34,885,000
Significant Other Unobservable Inputs (Level 3) [Member] | U.S. Treasury Securities [Member]
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Investments held in Trust Account		[1]		[2]
[1]	Excludes $390 of cash balance held within the Trust Account.
[2]	Excludes $569 of cash balance held within the Trust Account.

Fair Value Measurements - Sum_2

Fair Value Measurements - Summary of financial Asset measured at fair value on recurring basis (Parenthetical) (Detail) - USD ($)	Jun. 30, 2021	Dec. 31, 2020
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Cash	$ 170	$ 1,569,739
U.S. Treasury Securities [Member]
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Cash	$ 390	$ 569

Fair Value Measurements - Sum_3

Fair Value Measurements - Summary of fair value measurements inputs (Detail) - Fair Value, Inputs, Level 3 [Member]	Jun. 30, 2021	Dec. 31, 2020
Measurement Input, Exercise Price [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and Rights Outstanding, Measurement Input	11.50	11.50
Measurement Input, Share Price [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and Rights Outstanding, Measurement Input	10.69	10.84
Measurement Input, Price Volatility [Member] | Minimum [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and Rights Outstanding, Measurement Input	0.405	0.227
Measurement Input, Price Volatility [Member] | Maximum [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and Rights Outstanding, Measurement Input	0.452	0.443
Measurement Input, Expected Term [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and Rights Outstanding, Measurement Input	5.25	6.42
Measurement Input, Risk Free Interest Rate [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and Rights Outstanding, Measurement Input	0.0091	0.0057
Measurement Input, Expected Dividend Rate [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and Rights Outstanding, Measurement Input	0	0

Fair Value Measurements -Summar

Fair Value Measurements -Summary of change in the fair value of the derivative warrant liabilities (Detail) - USD ($)	3 Months Ended	6 Months Ended
	Jun. 30, 2021	Jun. 30, 2021
Schedule Of Changes In The Fair Value Of Warrant Liabilities [Line Items]
Change in fair value of derivative warrant liabilities	$ 7,510,000	$ 5,715,000
Fair Value, Inputs, Level 3 [Member]
Schedule Of Changes In The Fair Value Of Warrant Liabilities [Line Items]
Derivative warrant liabilities at December 31, 2020		34,885,000
Transfer to Level 1		(16,725,000)
Change in fair value of derivative warrant liabilities		(1,560,000)
Derivative warrant liabilities at March 31, 2021	$ 16,600,000	$ 16,600,000

Fair Value Measurements - Addit

Fair Value Measurements - Additional Information (Detail)	3 Months Ended	6 Months Ended
	Jun. 30, 2021USD ($)$ / shares	Jun. 30, 2021USD ($)$ / shares
Schedule Of Changes In The Fair Value Of Warrant Liabilities [Line Items]
Change in fair value of derivative warrant liabilities | $	$ 7,510,000	$ 5,715,000
Public Warrants [Member]
Schedule Of Changes In The Fair Value Of Warrant Liabilities [Line Items]
Class of warrants, exercise price per share | $ / shares	$ 3.20	$ 3.20